Bel200 ml

Bel is a traditional herbal formulation combining unripe Bael fruit (Aegle marmelos) and Connessi bark (Holarrhena antidysenterica), both long used in South Asian traditional and Ayurvedic/Unani medicine systems for gastrointestinal complaints.

Traditional/Evidence-Limited Uses

• Symptomatic relief of acute non-specific diarrhea
• Adjunct symptomatic use in dysentery-type loose motions (with mucus, without high fever or blood, mild-to-moderate)
• General digestive/gastrointestinal discomfort associated with loose stools, as used traditionally

These uses are based on longstanding traditional/folk use and limited pharmacological and small clinical studies rather than large-scale randomized controlled trials or formal regulatory (e.g., FDA) approval. Bel is not a substitute for oral rehydration therapy or for medical evaluation of severe, persistent, or bloody diarrhea.

Each unit of Belgiri [Bael fruit + Connessi bark] contains a standardized extract/preparation of:

• Bael fruit (Aegle marmelos) – unripe fruit pulp extract
• Connessi bark (Holarrhena antidysenterica) – stem bark extract

Exact strengths and excipients vary by manufacturer formulation and pack size; refer to the product label for the specific quantity per dose.

Bel is a fixed combination herbal medicine. Bael fruit has traditionally been used for its astringent, anti-diarrheal properties attributed to tannins and mucilage that may help firm stools and soothe the intestinal lining. Connessi bark contains the alkaloid conessine and related steroidal alkaloids, traditionally used in the Indian subcontinent for amoebic dysentery and diarrhea. Together, Bel is marketed as a traditional remedy for digestive upset with loose motions.

Modern pharmacological evidence for this combination is limited to preclinical/animal studies and traditional use documentation rather than robust human clinical trial data; it should be regarded as a supportive traditional remedy, not a proven treatment for infectious or invasive dysentery.

Bel belongs to the traditional herbal/phytopharmaceutical class of anti-diarrheal and antidysenteric preparations (herbal gastrointestinal remedies), rather than a conventional single-molecule pharmacological class.

Mechanism (Traditional/Preclinical Basis)

Belgiri [Bael fruit + Connessi bark] combines two plant sources with complementary traditional actions:

• Bael fruit (Aegle marmelos): Contains tannins, mucilage, and marmelosin. Tannins are thought to exert an astringent effect on the intestinal mucosa, reducing secretion and firming stool consistency; mucilage may have a soothing, demulcent effect on irritated gut lining.
• Connessi bark (Holarrhena antidysenterica): Contains conessine and related steroidal alkaloids, which in preclinical studies have shown antiprotozoal (including anti-amoebic), antibacterial, and antispasmodic activity, historically underlying its traditional use in dysentery.

These actions are described from traditional pharmacognosy and limited experimental data; Belgiri [Bael fruit + Connessi bark] has not undergone the pharmacokinetic characterization (absorption, distribution, metabolism, excretion) typical of conventional regulatory-approved drugs.

Bel is taken orally, preferably with or after meals and with adequate fluid/ORS intake. Swallow tablets/capsules with water, or take liquid/syrup formulations with the measuring device provided; shake liquid preparations well before use if applicable.

Known/Plausible Interactions

• Other antidiarrheal or antimotility agents (e.g., loperamide): Concurrent use with Bel is not well studied; combining antimotility agents in infectious diarrhea may theoretically slow clearance of pathogens/toxins and is generally discouraged without medical advice.
• Oral medications requiring consistent gut transit/absorption (e.g., narrow therapeutic index drugs): The astringent tannin content of Bael fruit may theoretically reduce absorption of some concurrently administered oral drugs if taken at the same time; spacing doses by 1-2 hours is a reasonable precaution.
• Other herbal or antidysenteric products containing similar plant alkaloids: Avoid duplicating therapy with other Holarrhena- or Aegle marmelos-containing products to prevent additive effects.

Formal drug-interaction studies for Bel are lacking; inform your physician or pharmacist of all medicines and supplements you are taking.

Reported adverse effects of Bel are generally mild and infrequent, based on traditional use experience:

• Constipation or hard stools (from excessive astringent effect)
• Mild abdominal discomfort, bloating, or nausea
• Allergic skin reactions (rash, itching) in sensitized individuals – rare

Stop use and consult a physician if any persistent or severe reaction occurs.

Safety data for Bel in pregnancy and lactation are limited. As with most herbal products lacking robust reproductive safety studies, Bel should be used during pregnancy or breastfeeding only if clearly needed and if potential benefit justifies potential risk, and only after consulting a physician.

• Bel is intended for short-term symptomatic relief of mild acute diarrhea; it is not a substitute for oral rehydration therapy (ORS), which should take priority, especially in children and the elderly.
• Seek prompt medical attention rather than relying on Bel alone if diarrhea is severe, persistent beyond 48 hours, accompanied by high fever, blood/mucus in stool, or signs of dehydration (reduced urination, dizziness, dry mouth, sunken eyes).
• Use with caution in patients with chronic gastrointestinal, hepatic, or renal disease.
• See Contraindications for hypersensitivity information.

Specific overdose data for Bel are not well documented. Excessive intake may worsen constipation, abdominal discomfort, or nausea. If overdose is suspected or symptoms are severe, seek immediate medical attention or contact a poison control center/emergency services rather than attempting home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Pediatric Use

Use of Bel in children should be at a reduced, age-appropriate dose and only under medical or pharmacist supervision; oral rehydration remains the priority in pediatric diarrhea. Safety and efficacy in infants and young children are not well established.

Elderly Use

No specific dose adjustment is established for elderly patients using Bel; use with routine caution given potentially reduced physiological reserve and higher dehydration risk.

Renal/Hepatic Impairment

No well-established dose-adjustment data exist for renal or hepatic impairment; use cautiously and under medical guidance.

Bel is generally intended for short-term use during an acute diarrhea episode (typically a few days). If symptoms do not improve within 48 hours, or worsen, discontinue and seek medical evaluation rather than continuing self-treatment.

Herbal anti-diarrheal / antidysenteric combination (traditional phytomedicine); not classified under a conventional single-molecule pharmacological class.

Belgiri [Bael fruit + Connessi bark] is believed to act through the astringent, mucosal-protective, and mild antimicrobial/antiprotozoal properties of its two plant components — Bael fruit tannins reducing intestinal secretion and firming stool, and Connessi bark alkaloids (notably conessine) providing traditional antidysenteric and antispasmodic activity — based on traditional pharmacognosy and preclinical studies rather than a single defined molecular mechanism.

Pediatric use of Bel should be limited to reduced, age-appropriate doses under medical or pharmacist supervision. Safety and efficacy have not been formally established in infants and young children; oral rehydration solution (ORS) remains the cornerstone of managing pediatric diarrhea, and Bel should only be used as an adjunct, not a replacement, for rehydration and medical care when indicated.